Abbotskerswell Veterinary Centre Limited - Period Ending 2020-09-30

Abbotskerswell Veterinary Centre Limited - Period Ending 2020-09-30


Abbotskerswell Veterinary Centre Limited 10387254 false 2019-10-01 2020-09-30 2020-09-30 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.29.9459.0 Software true true 10387254 2019-10-01 2020-09-30 10387254 2020-09-30 10387254 bus:OrdinaryShareClass1 2020-09-30 10387254 bus:OrdinaryShareClass2 2020-09-30 10387254 bus:Consolidated 2020-09-30 10387254 core:RetainedEarningsAccumulatedLosses 2020-09-30 10387254 core:ShareCapital 2020-09-30 10387254 core:CurrentFinancialInstruments 2020-09-30 10387254 core:CurrentFinancialInstruments core:WithinOneYear 2020-09-30 10387254 core:Non-currentFinancialInstruments 2020-09-30 10387254 core:Non-currentFinancialInstruments core:AfterOneYear 2020-09-30 10387254 core:Goodwill 2020-09-30 10387254 core:PatentsTrademarksLicencesConcessionsSimilar 2020-09-30 10387254 core:FurnitureFittingsToolsEquipment 2020-09-30 10387254 core:OtherPropertyPlantEquipment 2020-09-30 10387254 bus:SmallEntities 2019-10-01 2020-09-30 10387254 bus:Audited 2019-10-01 2020-09-30 10387254 bus:FullAccounts 2019-10-01 2020-09-30 10387254 bus:SmallCompaniesRegimeForAccounts 2019-10-01 2020-09-30 10387254 bus:RegisteredOffice 2019-10-01 2020-09-30 10387254 bus:Director1 2019-10-01 2020-09-30 10387254 bus:Director2 2019-10-01 2020-09-30 10387254 bus:OrdinaryShareClass1 2019-10-01 2020-09-30 10387254 bus:OrdinaryShareClass2 2019-10-01 2020-09-30 10387254 bus:Consolidated 2019-10-01 2020-09-30 10387254 bus:PrivateLimitedCompanyLtd 2019-10-01 2020-09-30 10387254 bus:Agent1 2019-10-01 2020-09-30 10387254 core:Goodwill 2019-10-01 2020-09-30 10387254 core:IntangibleAssetsOtherThanGoodwill 2019-10-01 2020-09-30 10387254 core:PatentsTrademarksLicencesConcessionsSimilar 2019-10-01 2020-09-30 10387254 core:FurnitureFittingsToolsEquipment 2019-10-01 2020-09-30 10387254 core:LandBuildings 2019-10-01 2020-09-30 10387254 core:OfficeEquipment 2019-10-01 2020-09-30 10387254 core:OtherPropertyPlantEquipment 2019-10-01 2020-09-30 10387254 countries:AllCountries 2019-10-01 2020-09-30 10387254 2019-09-30 10387254 core:Goodwill 2019-09-30 10387254 core:PatentsTrademarksLicencesConcessionsSimilar 2019-09-30 10387254 core:FurnitureFittingsToolsEquipment 2019-09-30 10387254 core:OtherPropertyPlantEquipment 2019-09-30 10387254 2019-03-20 2019-09-30 10387254 2019-09-30 10387254 bus:OrdinaryShareClass1 2019-09-30 10387254 bus:OrdinaryShareClass2 2019-09-30 10387254 bus:Consolidated 2019-09-30 10387254 core:RetainedEarningsAccumulatedLosses 2019-09-30 10387254 core:ShareCapital 2019-09-30 10387254 core:CurrentFinancialInstruments 2019-09-30 10387254 core:CurrentFinancialInstruments core:WithinOneYear 2019-09-30 10387254 core:Non-currentFinancialInstruments 2019-09-30 10387254 core:Non-currentFinancialInstruments core:AfterOneYear 2019-09-30 10387254 core:Goodwill 2019-09-30 10387254 core:PatentsTrademarksLicencesConcessionsSimilar 2019-09-30 10387254 core:FurnitureFittingsToolsEquipment 2019-09-30 10387254 core:OtherPropertyPlantEquipment 2019-09-30 10387254 bus:Consolidated 2019-03-20 2019-09-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10387254

Prepared for the registrar

Abbotskerswell Veterinary Centre Limited

Annual Report and Financial Statements

for the Year Ended 30 September 2020

 

Abbotskerswell Veterinary Centre Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3 to 10

 

Abbotskerswell Veterinary Centre Limited

Company Information

Directors

D L Chapman

M A Gillings

Registered office

The Chocolate Factory
Keynsham
Bristol
BS31 2AU

Bankers

HSBC Bank PLC
Second Floor
HSBC Building
Mitchell Way
Southampton
SO18 2XU

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Abbotskerswell Veterinary Centre Limited

(Registration number: 10387254)
Balance Sheet as at 30 September 2020

Note

30 September 2020
 £

Unaudited
30 September 2019
 £

Fixed assets

 

Intangible assets

4

-

187,154

Tangible assets

5

-

239,749

 

-

426,903

Current assets

 

Stocks

6

-

19,741

Debtors: Amounts falling due within one year

7

-

43,935

Debtors: Amounts falling due after more than one year

7

1,000

-

Cash at bank and in hand

 

-

348,157

 

1,000

411,833

Creditors: Amounts falling due within one year

8

-

(184,510)

Net current assets

 

1,000

227,323

Total assets less current liabilities

 

1,000

654,226

Creditors: Amounts falling due after more than one year

8

-

(297,793)

Net assets

 

1,000

356,433

Capital and reserves

 

Called up share capital

9

1,000

1,000

Profit and loss account

-

355,433

Total equity

 

1,000

356,433

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 17 December 2020 and signed on its behalf by:
 

.........................................

D L Chapman
Director

 

Abbotskerswell Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 30 September 2020

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
The Chocolate Factory
Keynsham
Bristol
BS31 2AU

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Name of parent of group

These financial statements are consolidated in the financial statements of IVC Acquisition Midco Ltd.

The financial statements of IVC Acquisition Midco Ltd may be obtained from Companies House.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements. This statement is made subject to all of the potential implications of the current COVID-19 outbreak on the company's trade, employees, customers, suppliers and the wider economy, as these are difficult to evaluate. Actual results could therefore be significantly different from the current forecasts and projections.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

 

Abbotskerswell Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 30 September 2020

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing on the initial transaction dates.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Short leasehold property

Over the term of the lease

Fixtures and surgery equipment

Straight line over 5 years

Office equipment

Straight line over 3 years

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

Straight line over 5 years

Intellectual property

Not depreciated

 

Abbotskerswell Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 30 September 2020

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Abbotskerswell Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 30 September 2020

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

 

Abbotskerswell Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 30 September 2020

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

Year ended 30 September 2020
 No.

Unaudited
20 March 2019 to 30 September 2019
 No.

Average number of employees

22

18

 

4

Intangible assets

Goodwill
 £

Intellectual property
£

Total
£

Cost

At 1 October 2019

276,000

4

276,004

Transferred to group undertaking

(276,000)

(4)

(276,004)

At 30 September 2020

-

-

-

Amortisation

At 1 October 2019

88,850

-

88,850

Amortisation charge

10,397

-

10,397

Transferred to group undertaking

(99,247)

-

(99,247)

At 30 September 2020

-

-

-

Carrying amount

At 30 September 2020

-

-

-

At 30 September 2019

187,150

4

187,154

 

Abbotskerswell Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 30 September 2020

 

5

Tangible assets

Fixtures and surgery equipment
 £

Computer equipment
 £

Total
£

Cost

At 1 October 2019

568,705

8,670

577,375

Additions

6,599

-

6,599

Transferred to group undertaking

(575,304)

(8,670)

(583,974)

At 30 September 2020

-

-

-

Depreciation

At 1 October 2019

332,341

5,285

337,626

Charge for the year

27,032

882

27,914

Transferred to group undertaking

(359,373)

(6,167)

(365,540)

At 30 September 2020

-

-

-

Carrying amount

At 30 September 2020

-

-

-

At 30 September 2019

236,364

3,385

239,749

On 31 December 2019, all of the fixed assets were transferred into Independent Vetcare Limited as part of a hive up of the company's trade and net assets carried out.

 

6

Stocks

30 September 2020
 £

Unaudited
30 September 2019
 £

Finished goods and consumables

-

19,741

 

7

Debtors

30 September 2020
 £

Unaudited
30 September 2019
 £

Trade debtors

-

19,651

Other debtors

-

5,662

Prepayments

-

11,002

Deferred tax assets

-

7,620

Amounts owed by group undertakings

1,000

-

 

1,000

43,935

Less non-current portion

(1,000)

-

Total current trade and other debtors

-

43,935

Details of non-current trade and other debtors

 

Abbotskerswell Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 30 September 2020

£1,000 (2019 - £Nil) of Amounts owed from group undertakings is classified as non-current.

 

8

Creditors

30 September 2020
 £

Unaudited
30 September 2019
 £

Due within one year

Trade creditors

-

36,774

Social security and other taxes

-

55,291

Outstanding defined contribution pension costs

-

3,862

Other creditors

-

21,608

Accrued expenses

-

35,958

Corporation tax liability

-

31,017

-

184,510

Due after one year

Amounts owed to group undertakings

-

297,793

 

9

Share capital

Allotted, called up and fully paid shares

 

30 September 2020

Unaudited
30 September 2019

 

No.

£

No.

£

Ordinary A shares of £1 each

750

750

750

750

Ordinary B shares of £1 each

250

250

250

250

 

1,000

1,000

1,000

1,000

Rights, preferences and restrictions

The different classes of share referred to above carry separate rights to dividends but, in all other significant respects, rank pari passu.

 

10

Pension and other schemes

Defined contribution pension scheme

The group operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the group to the scheme and amounted to £4,095 (2019 - £8,378).

Contributions totalling £nil (2019 - £3,862) were payable to the scheme at the end of the year and are included in creditors.

 

11

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £Nil (2019 - £572,024).

 

Abbotskerswell Veterinary Centre Limited

Notes to the Financial Statements for the Year Ended 30 September 2020

 

12

Parent and ultimate parent undertaking

The immediate parent company is Independent Vetcare Limited, incorporated in England and Wales.

The ultimate parent undertaking is IVC New TopHolding S.A., a company registered in Luxembourg.

 

13

Disclosure under Section 444(5B) CA 2006 relating to the independent auditor's report

As permitted by Section 444 CA 2006, these accounts do not contain a copy of the company’s Profit and Loss account or a copy of the Directors’ Report. Accordingly, the Independent Auditors’ Report has also been omitted.

The Independent Auditor's Report was unqualified. The corresponding figures for the period from 20 March 2019 to 30 September 2019 shown in the financial statements are derived from the financial statements prepared for that period that were not audited. The name of the Senior Statutory Auditor who signed the audit report on 17 December 2020 was Simon Worsley, who signed for and on behalf of Hazlewoods LLP.